The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sitagliptin Phosphate Tablets Market Research Report 2024

Global Sitagliptin Phosphate Tablets Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1738025

No of Pages : 101

Synopsis
Global Sitagliptin Phosphate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sitagliptin Phosphate Tablets market research.

Key manufacturers engaged in the Sitagliptin Phosphate Tablets industry include Yangtze River Pharmaceutical Group Co.,Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Merck Sharp & Dohme B.V., Dr. Reddy's Laboratories Limited, Gan & Lee Pharmaceuticals., Tonghua Dongbao Pharmaceutical Co.,Ltd., Shandong Langnuo Pharmaceutical Co., Ltd., Qilu Pharmaceutical (Hainan) Co., Ltd. and Sichuan Kelun Pharmaceutical Co.,Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Sitagliptin Phosphate Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sitagliptin Phosphate Tablets market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sitagliptin Phosphate Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Yangtze River Pharmaceutical Group Co.,Ltd.
  • Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
  • Merck Sharp & Dohme B.V.
  • Dr. Reddy's Laboratories Limited
  • Gan & Lee Pharmaceuticals.
  • Tonghua Dongbao Pharmaceutical Co.,Ltd.
  • Shandong Langnuo Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical (Hainan) Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co.,Ltd.
  • Sunshine Lake Pharma Co., Ltd.
  • Zhejiang Huahai Pharmaceutical Co.,Ltd.
  • Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory.
  • Zhejiang Nuode Pharmaceutical Co., Ltd.
  • CSPC Ouyi Pharmaceutical Co.,Ltd.
  • Cisen Pharmaceutical Co., Ltd.
  • Lepu Pharmaceutical Technology Co., Ltd.

Segment by Type

  • 25mg
  • 50mg
  • Others

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Sitagliptin Phosphate Tablets report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Sitagliptin Phosphate Tablets Market Overview
1.1 Product Overview and Scope of Sitagliptin Phosphate Tablets
1.2 Sitagliptin Phosphate Tablets Segment by Type
1.2.1 Global Sitagliptin Phosphate Tablets Market Value Comparison by Type (2023-2029)
1.2.2 25mg
1.2.3 50mg
1.2.4 Others
1.3 Sitagliptin Phosphate Tablets Segment by Application
1.3.1 Global Sitagliptin Phosphate Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Sitagliptin Phosphate Tablets Market Size Estimates and Forecasts
1.4.1 Global Sitagliptin Phosphate Tablets Revenue 2018-2029
1.4.2 Global Sitagliptin Phosphate Tablets Sales 2018-2029
1.4.3 Global Sitagliptin Phosphate Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sitagliptin Phosphate Tablets Market Competition by Manufacturers
2.1 Global Sitagliptin Phosphate Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sitagliptin Phosphate Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sitagliptin Phosphate Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Sitagliptin Phosphate Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sitagliptin Phosphate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sitagliptin Phosphate Tablets, Product Type & Application
2.7 Sitagliptin Phosphate Tablets Market Competitive Situation and Trends
2.7.1 Sitagliptin Phosphate Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sitagliptin Phosphate Tablets Players Market Share by Revenue
2.7.3 Global Sitagliptin Phosphate Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sitagliptin Phosphate Tablets Retrospective Market Scenario by Region
3.1 Global Sitagliptin Phosphate Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sitagliptin Phosphate Tablets Global Sitagliptin Phosphate Tablets Sales by Region: 2018-2029
3.2.1 Global Sitagliptin Phosphate Tablets Sales by Region: 2018-2023
3.2.2 Global Sitagliptin Phosphate Tablets Sales by Region: 2024-2029
3.3 Global Sitagliptin Phosphate Tablets Global Sitagliptin Phosphate Tablets Revenue by Region: 2018-2029
3.3.1 Global Sitagliptin Phosphate Tablets Revenue by Region: 2018-2023
3.3.2 Global Sitagliptin Phosphate Tablets Revenue by Region: 2024-2029
3.4 North America Sitagliptin Phosphate Tablets Market Facts & Figures by Country
3.4.1 North America Sitagliptin Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sitagliptin Phosphate Tablets Sales by Country (2018-2029)
3.4.3 North America Sitagliptin Phosphate Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sitagliptin Phosphate Tablets Market Facts & Figures by Country
3.5.1 Europe Sitagliptin Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sitagliptin Phosphate Tablets Sales by Country (2018-2029)
3.5.3 Europe Sitagliptin Phosphate Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sitagliptin Phosphate Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Sitagliptin Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sitagliptin Phosphate Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Sitagliptin Phosphate Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sitagliptin Phosphate Tablets Market Facts & Figures by Country
3.7.1 Latin America Sitagliptin Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sitagliptin Phosphate Tablets Sales by Country (2018-2029)
3.7.3 Latin America Sitagliptin Phosphate Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sitagliptin Phosphate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Sitagliptin Phosphate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sitagliptin Phosphate Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sitagliptin Phosphate Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sitagliptin Phosphate Tablets Sales by Type (2018-2029)
4.1.1 Global Sitagliptin Phosphate Tablets Sales by Type (2018-2023)
4.1.2 Global Sitagliptin Phosphate Tablets Sales by Type (2024-2029)
4.1.3 Global Sitagliptin Phosphate Tablets Sales Market Share by Type (2018-2029)
4.2 Global Sitagliptin Phosphate Tablets Revenue by Type (2018-2029)
4.2.1 Global Sitagliptin Phosphate Tablets Revenue by Type (2018-2023)
4.2.2 Global Sitagliptin Phosphate Tablets Revenue by Type (2024-2029)
4.2.3 Global Sitagliptin Phosphate Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Sitagliptin Phosphate Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sitagliptin Phosphate Tablets Sales by Application (2018-2029)
5.1.1 Global Sitagliptin Phosphate Tablets Sales by Application (2018-2023)
5.1.2 Global Sitagliptin Phosphate Tablets Sales by Application (2024-2029)
5.1.3 Global Sitagliptin Phosphate Tablets Sales Market Share by Application (2018-2029)
5.2 Global Sitagliptin Phosphate Tablets Revenue by Application (2018-2029)
5.2.1 Global Sitagliptin Phosphate Tablets Revenue by Application (2018-2023)
5.2.2 Global Sitagliptin Phosphate Tablets Revenue by Application (2024-2029)
5.2.3 Global Sitagliptin Phosphate Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Sitagliptin Phosphate Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Yangtze River Pharmaceutical Group Co.,Ltd.
6.1.1 Yangtze River Pharmaceutical Group Co.,Ltd. Corporation Information
6.1.2 Yangtze River Pharmaceutical Group Co.,Ltd. Description and Business Overview
6.1.3 Yangtze River Pharmaceutical Group Co.,Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Yangtze River Pharmaceutical Group Co.,Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.1.5 Yangtze River Pharmaceutical Group Co.,Ltd. Recent Developments/Updates
6.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
6.2.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Corporation Information
6.2.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.2.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Merck Sharp & Dohme B.V.
6.3.1 Merck Sharp & Dohme B.V. Corporation Information
6.3.2 Merck Sharp & Dohme B.V. Description and Business Overview
6.3.3 Merck Sharp & Dohme B.V. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck Sharp & Dohme B.V. Sitagliptin Phosphate Tablets Product Portfolio
6.3.5 Merck Sharp & Dohme B.V. Recent Developments/Updates
6.4 Dr. Reddy's Laboratories Limited
6.4.1 Dr. Reddy's Laboratories Limited Corporation Information
6.4.2 Dr. Reddy's Laboratories Limited Description and Business Overview
6.4.3 Dr. Reddy's Laboratories Limited Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dr. Reddy's Laboratories Limited Sitagliptin Phosphate Tablets Product Portfolio
6.4.5 Dr. Reddy's Laboratories Limited Recent Developments/Updates
6.5 Gan & Lee Pharmaceuticals.
6.5.1 Gan & Lee Pharmaceuticals. Corporation Information
6.5.2 Gan & Lee Pharmaceuticals. Description and Business Overview
6.5.3 Gan & Lee Pharmaceuticals. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Gan & Lee Pharmaceuticals. Sitagliptin Phosphate Tablets Product Portfolio
6.5.5 Gan & Lee Pharmaceuticals. Recent Developments/Updates
6.6 Tonghua Dongbao Pharmaceutical Co.,Ltd.
6.6.1 Tonghua Dongbao Pharmaceutical Co.,Ltd. Corporation Information
6.6.2 Tonghua Dongbao Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 Tonghua Dongbao Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Tonghua Dongbao Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.6.5 Tonghua Dongbao Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.7 Shandong Langnuo Pharmaceutical Co., Ltd.
6.6.1 Shandong Langnuo Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Shandong Langnuo Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Shandong Langnuo Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shandong Langnuo Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.7.5 Shandong Langnuo Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Qilu Pharmaceutical (Hainan) Co., Ltd.
6.8.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Corporation Information
6.8.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Description and Business Overview
6.8.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.8.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
6.9 Sichuan Kelun Pharmaceutical Co.,Ltd.
6.9.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Corporation Information
6.9.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
6.9.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.9.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.10 Sunshine Lake Pharma Co., Ltd.
6.10.1 Sunshine Lake Pharma Co., Ltd. Corporation Information
6.10.2 Sunshine Lake Pharma Co., Ltd. Description and Business Overview
6.10.3 Sunshine Lake Pharma Co., Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sunshine Lake Pharma Co., Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.10.5 Sunshine Lake Pharma Co., Ltd. Recent Developments/Updates
6.11 Zhejiang Huahai Pharmaceutical Co.,Ltd.
6.11.1 Zhejiang Huahai Pharmaceutical Co.,Ltd. Corporation Information
6.11.2 Zhejiang Huahai Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Description and Business Overview
6.11.3 Zhejiang Huahai Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhejiang Huahai Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.11.5 Zhejiang Huahai Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.12 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory.
6.12.1 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. Corporation Information
6.12.2 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. Sitagliptin Phosphate Tablets Description and Business Overview
6.12.3 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. Sitagliptin Phosphate Tablets Product Portfolio
6.12.5 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. Recent Developments/Updates
6.13 Zhejiang Nuode Pharmaceutical Co., Ltd.
6.13.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Corporation Information
6.13.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Description and Business Overview
6.13.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.13.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 CSPC Ouyi Pharmaceutical Co.,Ltd.
6.14.1 CSPC Ouyi Pharmaceutical Co.,Ltd. Corporation Information
6.14.2 CSPC Ouyi Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Description and Business Overview
6.14.3 CSPC Ouyi Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 CSPC Ouyi Pharmaceutical Co.,Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.14.5 CSPC Ouyi Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.15 Cisen Pharmaceutical Co., Ltd.
6.15.1 Cisen Pharmaceutical Co., Ltd. Corporation Information
6.15.2 Cisen Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Description and Business Overview
6.15.3 Cisen Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Cisen Pharmaceutical Co., Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.15.5 Cisen Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Lepu Pharmaceutical Technology Co., Ltd.
6.16.1 Lepu Pharmaceutical Technology Co., Ltd. Corporation Information
6.16.2 Lepu Pharmaceutical Technology Co., Ltd. Sitagliptin Phosphate Tablets Description and Business Overview
6.16.3 Lepu Pharmaceutical Technology Co., Ltd. Sitagliptin Phosphate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Lepu Pharmaceutical Technology Co., Ltd. Sitagliptin Phosphate Tablets Product Portfolio
6.16.5 Lepu Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sitagliptin Phosphate Tablets Industry Chain Analysis
7.2 Sitagliptin Phosphate Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sitagliptin Phosphate Tablets Production Mode & Process
7.4 Sitagliptin Phosphate Tablets Sales and Marketing
7.4.1 Sitagliptin Phosphate Tablets Sales Channels
7.4.2 Sitagliptin Phosphate Tablets Distributors
7.5 Sitagliptin Phosphate Tablets Customers
8 Sitagliptin Phosphate Tablets Market Dynamics
8.1 Sitagliptin Phosphate Tablets Industry Trends
8.2 Sitagliptin Phosphate Tablets Market Drivers
8.3 Sitagliptin Phosphate Tablets Market Challenges
8.4 Sitagliptin Phosphate Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’